Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic Application of Tranexamic Acid and Sucralfate in Gastrointestinal Tumor Bleeding
NCT07540026Recruiting
- Sponsor
- National Cheng Kung University Hospital
- Start
- May 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tranexamic acid and sucralfate in gastrointestinal bleeding (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoints: 30-day rebleeding and Immediate hemostasis at 3 minutes. Started May 2026; status: recruiting.
02
Drugs
tranexamic acidsucralfate
03
Conditions
gastrointestinal bleeding
Beyond the preview
Go deeper on NCT07540026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07540026.